China Regenerative Medicine International | Sustainability Performance
Develops and commercializes biomedical technologies including tissue engineering, stem cell applications, and regenerative treatments. Its offerings are aimed at clinical, surgical, and research environments, with a focus on innovation and licensing.
1995
Hong Kong
11 - 50 employees
Biotechnology
$1M - 10M in revenue
$1M - 10M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#8240
Overallⓘ#140
in Hong Kongⓘ#189
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Controversy level
Powered by illuminem
